vs

Side-by-side financial comparison of PEDEVCO CORP (PED) and SOLESENCE, INC. (SLSN). Click either name above to swap in a different company.

PEDEVCO CORP is the larger business by last-quarter revenue ($23.1M vs $12.5M, roughly 1.8× SOLESENCE, INC.). SOLESENCE, INC. runs the higher net margin — 1.3% vs -36.8%, a 38.1% gap on every dollar of revenue. On growth, PEDEVCO CORP posted the faster year-over-year revenue change (118.2% vs -0.7%). Over the past eight quarters, PEDEVCO CORP's revenue compounded faster (68.6% CAGR vs 12.5%).

PEDEVCO Corp is an independent energy company specializing in the acquisition, exploration, development, and production of oil and natural gas assets. It primarily holds and operates onshore resource properties across continental US basins, serving domestic wholesale, utility, and industrial energy customer segments.

PED vs SLSN — Head-to-Head

Bigger by revenue
PED
PED
1.8× larger
PED
$23.1M
$12.5M
SLSN
Growing faster (revenue YoY)
PED
PED
+118.9% gap
PED
118.2%
-0.7%
SLSN
Higher net margin
SLSN
SLSN
38.1% more per $
SLSN
1.3%
-36.8%
PED
Faster 2-yr revenue CAGR
PED
PED
Annualised
PED
68.6%
12.5%
SLSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PED
PED
SLSN
SLSN
Revenue
$23.1M
$12.5M
Net Profit
$-8.5M
$163.0K
Gross Margin
27.5%
Operating Margin
-21.3%
1.5%
Net Margin
-36.8%
1.3%
Revenue YoY
118.2%
-0.7%
Net Profit YoY
-243.5%
129.2%
EPS (diluted)
$-2.23
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PED
PED
SLSN
SLSN
Q4 25
$23.1M
$12.5M
Q3 25
$7.0M
$14.6M
Q2 25
$7.0M
$20.4M
Q1 25
$8.7M
$14.6M
Q4 24
$10.6M
$12.6M
Q3 24
$9.1M
$16.9M
Q2 24
$11.8M
$13.0M
Q1 24
$8.1M
$9.9M
Net Profit
PED
PED
SLSN
SLSN
Q4 25
$-8.5M
$163.0K
Q3 25
$-325.0K
$-1.1M
Q2 25
$-1.7M
$2.7M
Q1 25
$140.0K
$80.0K
Q4 24
$5.9M
$-559.0K
Q3 24
$2.9M
$3.0M
Q2 24
$2.7M
$856.0K
Q1 24
$773.0K
$893.0K
Gross Margin
PED
PED
SLSN
SLSN
Q4 25
27.5%
Q3 25
23.1%
Q2 25
28.9%
Q1 25
23.1%
Q4 24
22.0%
Q3 24
36.2%
Q2 24
28.7%
Q1 24
36.3%
Operating Margin
PED
PED
SLSN
SLSN
Q4 25
-21.3%
1.5%
Q3 25
-12.0%
-5.4%
Q2 25
-32.2%
9.4%
Q1 25
1.7%
1.8%
Q4 24
-12.9%
-1.8%
Q3 24
31.3%
19.0%
Q2 24
22.3%
8.0%
Q1 24
7.6%
11.3%
Net Margin
PED
PED
SLSN
SLSN
Q4 25
-36.8%
1.3%
Q3 25
-4.7%
-7.7%
Q2 25
-24.0%
13.1%
Q1 25
1.6%
0.5%
Q4 24
56.0%
-4.4%
Q3 24
32.2%
18.1%
Q2 24
22.7%
6.6%
Q1 24
9.5%
9.0%
EPS (diluted)
PED
PED
SLSN
SLSN
Q4 25
$-2.23
$0.00
Q3 25
$0.00
$-0.02
Q2 25
$-0.02
$0.04
Q1 25
$0.00
$0.00
Q4 24
$2.69
$0.00
Q3 24
$0.03
$0.04
Q2 24
$0.03
$0.01
Q1 24
$0.01
$0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PED
PED
SLSN
SLSN
Cash + ST InvestmentsLiquidity on hand
$3.2M
$1.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$207.4M
$17.6M
Total Assets
$375.9M
$50.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PED
PED
SLSN
SLSN
Q4 25
$3.2M
$1.3M
Q3 25
$10.9M
$429.0K
Q2 25
$8.5M
$4.1M
Q1 25
$10.4M
$1.8M
Q4 24
$4.0M
$1.4M
Q3 24
$4.6M
$2.9M
Q2 24
$6.1M
$2.4M
Q1 24
$13.3M
$2.0M
Stockholders' Equity
PED
PED
SLSN
SLSN
Q4 25
$207.4M
$17.6M
Q3 25
$115.4M
$17.2M
Q2 25
$115.2M
$18.2M
Q1 25
$116.2M
$15.2M
Q4 24
$115.6M
$14.9M
Q3 24
$106.5M
$15.2M
Q2 24
$103.2M
$11.9M
Q1 24
$100.0M
$5.0M
Total Assets
PED
PED
SLSN
SLSN
Q4 25
$375.9M
$50.1M
Q3 25
$135.9M
$54.0M
Q2 25
$136.8M
$60.0M
Q1 25
$145.6M
$57.0M
Q4 24
$128.3M
$50.0M
Q3 24
$114.3M
$48.0M
Q2 24
$111.0M
$40.8M
Q1 24
$118.3M
$38.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PED
PED
SLSN
SLSN
Operating Cash FlowLast quarter
$-2.1M
$1.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
11.16×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PED
PED
SLSN
SLSN
Q4 25
$-2.1M
$1.8M
Q3 25
$7.4M
$-2.5M
Q2 25
$-420.0K
$-654.0K
Q1 25
$5.9M
$-7.2M
Q4 24
$4.2M
$2.2M
Q3 24
$8.3M
$4.2M
Q2 24
$4.6M
$-565.0K
Q1 24
$-4.3M
$-3.9M
Free Cash Flow
PED
PED
SLSN
SLSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-404.0K
Q3 24
$2.8M
Q2 24
$-1.0M
Q1 24
$-3.9M
FCF Margin
PED
PED
SLSN
SLSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-3.2%
Q3 24
16.6%
Q2 24
-8.0%
Q1 24
-39.9%
Capex Intensity
PED
PED
SLSN
SLSN
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
20.6%
Q3 24
8.3%
Q2 24
3.7%
Q1 24
0.9%
Cash Conversion
PED
PED
SLSN
SLSN
Q4 25
11.16×
Q3 25
Q2 25
-0.25×
Q1 25
42.34×
-90.26×
Q4 24
0.71×
Q3 24
2.83×
1.38×
Q2 24
1.71×
-0.66×
Q1 24
-5.56×
-4.32×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons